Patent Results

15 Results for: citation_id:21074045
Make Note

Methods And Compositions For Treating Neurological Disorders

  • Published: Nov 10, 2011
  • Family: 4
  • Cited by: 0
  • Cites: 1
  • Sequences: 20
  • Additional Info: Cited Works Full text Sequence
  • Applicant: Salk Inst For Biological Studi, Marchetto Maria C N, Gage Fred H, Muotri Alysson R

In Vitro Model Of Spinal Muscular Atrophy

  • Published: Jul 3, 2012
  • Family: 3
  • Cited by: 2
  • Sequences: 24
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Wisconsin Alumni Research Foundation
  • Applicant: Svendsen Clive, Ebert Allison, Wisconsin Alumni Res Found

Treatment Of Autism Spectrum Disorderes Using Glycyl-l-2-methylprolyl-l-glutamic Acid

  • Published: Aug 2, 2012
  • Family: 26
  • Cited by: 6
  • Cites: 33
  • Additional Info: Cited Works Published
  • Applicant: Neuren Pharmaceuticals Ltd, Glass Larry, Bickerdike Michael John, Snape Michael Frederick

Formulation For Regeneration Of Bone, Cartilage, Teeth, And Periodontium And Treatment Of Tumors And Cysts

Treatment Of Rett Syndrome Using Glycyl-l-2-methylprolyl-l-glutamic Acid

Method Of Screening For Substances Capable Of Promoting Induction Of Induced Pluripotent Stem Cells

  • Published: Dec 20, 2016
  • Family: 5
  • Cited by: 0
  • Cites: 1
  • Sequences: 60
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: National University Corporation Kumamoto University
  • Applicant: Era Takumi, Nat Univ Corp Kumamoto Univ

Method For Preparing An X Chromosome Inactivated Female Human Neural Cell

  • Published: Jul 4, 2017
  • Family: 4
  • Cited by: 0
  • Cites: 4
  • Sequences: 20
  • Additional Info: Cited Works Full text Sequence
  • Owner: Salk Institute For Biological Studies
  • Applicant: Marchetto Maria C N, Gage Fred H, Muotri Alysson R, Salk Inst For Biological Studi

Treatment Of Fragile X Syndrome Using Glycyl-l-2-methylprolyl-l-glutamate

  • Published: Jul 18, 2017
  • Family: 26
  • Cited by: 0
  • Cites: 22
  • Additional Info: Cited Works Full text
  • Owner: Neuren Pharmaceuticals Limited
  • Applicant: Glass Larry, Bickerdike Michael John, Snape Michael Frederick, Neuren Pharmaceuticals Ltd

Reprogramming-based Models Of Neurodevelopmental Disorders And Uses Thereof

  • Published: Jun 2, 2016
  • Family: 2
  • Cited by: 0
  • Cites: 1
  • Sequences: 32
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Ieo Istituto Europ Di Oncologia S R L, I R C C S “casa Sollievo Della Sofferenza”, Università Degli Studi Di Milano

Drug Screening Platform For Rett Syndrome

  • Published: Apr 30, 2015
  • Family: 4
  • Cited by: 5
  • Cites: 3
  • Additional Info: Cited Works Full text Published
  • Owner: The Regents Of The University Of California
  • Applicant: Univ California

Add Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save Query

Sign in to the Lens